Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Chubb
Farmers Insurance
Cerilliant
Queensland Health
Federal Trade Commission
Covington
Daiichi Sankyo
Express Scripts
Novartis

Generated: October 20, 2017

DrugPatentWatch Database Preview

ESTRATAB Drug Profile

« Back to Dashboard

Which patents cover Estratab, and what generic Estratab alternatives are available?

Estratab is a drug marketed by Solvay and is included in four NDAs.

The generic ingredient in ESTRATAB is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.

Summary for Tradename: ESTRATAB

US Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list6
Patent Applications: see list7,432
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ESTRATAB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay
ESTRATAB
estrogens, esterified
TABLET;ORAL083209-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
ESTRATAB
estrogens, esterified
TABLET;ORAL083857-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
ESTRATAB
estrogens, esterified
TABLET;ORAL086715-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
ESTRATAB
estrogens, esterified
TABLET;ORAL083856-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Merck
Chubb
Farmers Insurance
Deloitte
McKesson
Chinese Patent Office
Novartis
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot